CBA under the microscope
CONCAWE’s assessment of latest scientific information on valuation of benefits from aspects influencing mortality and morbidity factors reveals that proposed benefit numbers applied in recent Cost Benefit Analysis (CBA) studies supporting the current Air Policy review process are significantly overestimated.